Sunovion Pharmaceuticals, INC. (Formerly Known as Sepracor INC.)
🤖
AI Overview
With $1.4M in lobbying spend across 21 quarterly filings, Sunovion Pharmaceuticals, INC. (Formerly Known as Sepracor INC.) is a significant lobbying presence. Their lobbying covers 2 issue areas. Active from 2018 to 2023.
$1.4M
Total Spend
6
Years Active
1
Firms Hired
5
Lobbyists Deployed
2
Issues Lobbied
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2018 | $270K |
| 2019 | $280K |
| 2020 | $270K |
| 2021 | $280K |
| 2022 | $280K |
| 2023 | $70K |
Issues Lobbied
Lobbying Firms
Lobbyists
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Medicare/Medicaid, MED
- •Medicare reimbursement of prescription drugs; mental health legislation.
- •Medicare reimbursement of prescription drugs.
- •Drug innovation issues.
Related Analysis
Related Investigations
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.